Solar cells: Mapping the landscape of Caesium based inorganic halide perovskites

Nine samples with mixtures from CsPbBr<sub>2</sub>I (ink 1, left) to pure CsPbI<sub>3</sub> (ink 2 right).

Nine samples with mixtures from CsPbBr2I (ink 1, left) to pure CsPbI3 (ink 2 right). © H. Näsström/HZB

All samples have been printed in the HySPRINT-lab at HZB.

All samples have been printed in the HySPRINT-lab at HZB. © H. Näsström/HZB

Scientists at HZB have printed and explored different compositions of caesium based halide perovskites (CsPb(BrxI1−x)3 (0 ≤ x ≤ 1)). In a temperature range between room temperature and 300 Celsius, they observe structural phase transitions influencing the electronic properties. The study provides a quick and easy method to assess new compositions of perovskite materials in order to identify candidates for applications in thin film solar cells and optoelectronic devices.

Hybrid halide perovskites (ABX3) have risen up in only a few years as highly efficient new materials for thin film solar cells. The A stands for a cation, either an organic molecule or some alkali metal, the B is a metal, most often Lead (Pb) and the X is a halide element such as Bromide or Iodide. Currently some compositions achieve power conversion efficiencies above 25%. What is more, most perovskite thin films can easily be processed from solution at moderate processing temperatures, which is very economic.

World record efficiencies have been reached by organic molecules such as methylammonium (MA) as the A cation and Pb and Iodine or Bromide on the other sites. But those organic perovskites are not yet very stable. Inorganic perovskites with Caesium at the A-site promise higher stabilities, but simple compounds such as CsPbI3 or CsPbBr3 are either not very stable or do not provide the electronic properties needed for applications in solar cells or other optoelectronic devices.

Compositions of anorganic perovskites

Now, a team at HZB did explore compositions of CsPb(BrxI1−x)3, which provide tunable optical band gaps between 1.73 and 2.37 eV. This makes these mixtures really interesting for multi-junction solar cell applications, in particular for tandem devices.

Printing technique

For the production they used a newly developed method for printing combinatorial perovskite thin films to produce systematic variations of (CsPb(BrxI1−x)3 thin films onto a substrate. To achieve this, two print heads were filled with either CsPbBr2I or CsPbI3 and then programmed to print the required amount of liquid droplets onto the substrate to form a thin film of the wanted composition. After annealing at 100 Celsius to drive out the solvent and crystallise the sample, they obtained thin stripes with different compositions (shown in the picture).

Structure analysis in LIMAX Lab

With a special high intensity x-ray source, the liquid metal jet in the LIMAX lab at HZB, the crystalline structure of the thin film was analysed at different temperatures, ranging from room temperature up to 300 Celsius. “We find that all investigated compositions convert to a cubic perovskite phase at high temperature”, Hampus Näsström, PhD student and first author of the publication explains. Upon cooling down, all samples transition to metastable tetragonal and orthorhombic distorted perovskite phases, which make them suitable for solar cell devices. “This has proven to be an ideal use case of in-situ XRD with the lab-based high-brilliance X-ray source”, Roland Mainz, head of the LIMAX laboratory, adds.

Lower processing temperatures

Since the transition temperatures into the desired phases are found to decrease with increasing bromide content, this would allow to lower processing temperatures for inorganic perovskite solar cells.

High throughput approach accelerates optimization

“The interest in this new class of solar materials is huge, and the possible compositional variations near to infinite. This work demonstrates how to produce and assess systematically a wide range of compositions”, says Dr. Eva Unger, who heads the Young Investigator Group Hybrid Materials Formation and Scaling. Dr. Thomas Unold, head of the Combinatorial Energy Materials Research group agrees and suggests that “this is a prime example of how high-throughput approaches in research could vastly accelerate discovery and optimization of materials in future research”.

arö

  • Copy link

You might also be interested in

  • Protein crystallography at BESSY II: faster, better and more and more automatic
    Interview
    04.03.2026
    Protein crystallography at BESSY II: faster, better and more and more automatic
    Many diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with  Manfred Weiss, head of the research group for macromolecular crystallography. 
  • Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. Uhl
    News
    02.03.2026
    Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. Uhl
    Alexander R. Uhl, UBC Okanagan School of Engineering in Kelowna, Canada, aims to develop with Roel van de Krol from the HZB Institute for Solar Fuels an efficient and inexpensive photoelectrolyser for producing hydrogen using sunlight. His stay is being funded by the Alexander von Humboldt Foundation.
  • 5000th protein structure at BESSY II: Starting point for a COVID drug
    Science Highlight
    26.02.2026
    5000th protein structure at BESSY II: Starting point for a COVID drug
    Many proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.